Catalent Expands Global Clinical Supply Services

Catalent has undertaken two global expansion initiatives that enhance the company’s ability to provide better service in the controlled substance arena.

Catalent Pharma Solutions’ Clinical Supply Services business has recently undertaken two global expansion initiatives that enhance the company’s ability to provide better service in the controlled substance arena.

In the United States, Catalent’s Philadelphia site has benefited from a recently completed 3,000 square feet cage expansion which can accommodate DEA Schedule III-V drugs, as well as other special security and storage needs. The newly-approved DEA cage will provide 500 additional storage locations to existing capacity and provide additional storage, distribution, and return drug management capabilities.

Internationally, Catalent’s facilities in Schorndorf, Germany are also undergoing expansion. The expansion includes both additional c